Fluorescent-guided surgery for throat cancer patients
Part of Cancer clinical trials.
This study tests a special dye/light method during surgery for laryngeal and hypopharyngeal squamous cell cancer. The goal is to see if it’s safe and practical to help surgeons find the tumor more clearly.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have confirmed squamous cell cancer in the larynx or hypopharynx from a biopsy
- You are 18 years or older, and you can sign consent for the study
- You can read and understand Dutch well enough to complete the consent form
- You cannot be pregnant or breastfeeding
- Your kidneys must work well (eGFR 60 or higher, not on kidney-risk medicines you can’t stop)
- You should not have certain heart rhythm/strength and blood test issues (QTc under 500, and blood/organ tests not too abnormal)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 trial tests a special light-tracking medicine (cRGD-ZW800-1) to help surgeons see oral cancer during surgery. The goal is to improve how well the tumor is found and removed while keeping side effects manageable.
This study tests whether using special fluorescent dye during brain tumor surgery, combined with chemotherapy and radiation, helps the body's immune system fight glioblastoma (an aggressive brain cancer). Researchers will track immune markers in your blood over time to understand how these treatments work together.
This trial studies a dye-based technique (using indocyanine green) to help surgeons identify lung segments during a lung cancer operation (segmentectomy). The goal is to improve how accurately and safely surgeons remove the affected part of the lung.
This trial tests a special dye and imaging technique to help surgeons see and remove sarcoma tumors more completely. The goal is to reduce the chance that cancer cells are accidentally left behind during surgery.
This trial tests if a special dye (ICG) and a near-infrared camera can help surgeons see and protect a nerve that controls your voice box during minimally invasive esophagus cancer surgery. The goal is to reduce voice changes after surgery.
This trial tests a new way to remove liver cancer during surgery. A special dye called ICG is injected into the artery leading to the liver, which makes the tumor glow under a special camera, helping the surgeon remove just the right area. This study checks if this technique is both safe and effective for people with a common type of liver cancer (hepatocellular carcinoma).
Hear when a new Squamous Cell Carcinoma of the Larynx trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.